Plante Moran Financial Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Plante Moran Financial Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$166	Buy	+11	New	+$192	﹤0.01%	1490

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Plante Moran Financial Advisors's TNDM Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 11 shares worth $166. The stake represents ﹤0.01% of the portfolio and ranks #1490 among its holdings.

109 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Plante Moran Financial Advisors held 11 shares of Tandem Diabetes Care worth $166 as of Q2 2026.
Tandem Diabetes Care was a new Plante Moran Financial Advisors position in Q2 2026.
Tandem Diabetes Care made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1490 holding.
109 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.